Description de l'entreprise
bioMérieux S.A. is one of the world leaders in the field of in vitro diagnostics for over 50 years. bioMérieux is present in more than 160 countries through 42 subsidiaries and a large network of distributors. bioMérieux provides diagnostic solutions (reagents, instruments, software and services) which determine the source of disease and contamination to improve patient health and ensure product safety. In clinical applications, the Company offers a wide range of solutions for managing infectious diseases, cardiovascular diseases and targeted cancers. For the agri-food, cosmetics and pharmaceutical industries, bioMérieux provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing.
Conseil d'administration & Conseil de surveillance
| PDG |
| Pierre Boulud |
| Conseil d'administration |
| Guillaume Bouhours, Pierre Charbonnier, Audrey Dauvet, Valérie Leyldé, Yasha Mitrotti, Jennifer Zinn, Charles K. Cooper, Céline Roger-Dalbert |
| Conseil de surveillance |
| Alexandre Mérieux, Alain Mérieux, Jean-Luc Bélingard, Marie-Hélène Habert-Dassault, Philippe Archinard, Harold Boël, Fanny Letier, Marie-Paule Kieny, Sylvain Orenga, Viviane Monges, Benoît Ribadeau-Dumas |
Données de l'entreprise
| Nom: |
bioMerieux S.A. |
| Adresse: |
Chemin de l'Orme,F-69280 Marcy l'Etoile |
| Téléphone: |
+33-4-7887-2000 |
| Fax: |
+33-4-7887-2090 |
| Courriel: |
-
|
| Internet: |
www.biomerieux.com |
| Industrie: |
Healthcare |
| Secteur: |
Medical Products |
| Sous-secteur: |
Advanced Medical Devices |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
33.97% |
| IPO date: |
- |
